EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 85 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,093,199 | +43.7% | 136,821 | +56.5% | 0.00% | – |
| Q2 2023 | $760,588 | +189.6% | 87,424 | -2.1% | 0.00% | – |
| Q1 2023 | $262,658 | +206.5% | 89,339 | +264.9% | 0.00% | – |
| Q4 2022 | $85,698 | +8.5% | 24,485 | +143.8% | 0.00% | – |
| Q3 2022 | $79,000 | -13.2% | 10,043 | -14.2% | 0.00% | – |
| Q2 2022 | $91,000 | -19.5% | 11,711 | +26.6% | 0.00% | – |
| Q1 2022 | $113,000 | -53.5% | 9,248 | -53.5% | 0.00% | – |
| Q4 2021 | $243,000 | +279.7% | 19,893 | +221.9% | 0.00% | – |
| Q3 2021 | $64,000 | -57.3% | 6,180 | -63.1% | 0.00% | – |
| Q2 2021 | $150,000 | +383.9% | 16,744 | +456.3% | 0.00% | – |
| Q1 2021 | $31,000 | +138.5% | 3,010 | +49.8% | 0.00% | – |
| Q4 2020 | $13,000 | – | 2,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |